In addition to improved glycemic outcomes, patients report improvement in quality of life (QOL) with use of the tubeless insulin management system compared to their previous treatment modality.9 In a recent survey study by Polonsky and colleagues of more than 1200 adults with type 1 diabetes using the tubeless insulin management system, there were QOL and clinical benefits associated with use of this system.9 The majority of patients reported positive changes in overall well-being (53.5%), perceived control over diabetes (72.5%), hypoglycemic safety (50.6%), and diabetes distress (69.6%). Here, INS is linked to diabetes mellitus.